China has a fascinating and unique market for cord blood banking. To begin, the Chinese government only allows one cord blood bank in each of the Chinese provinces. The Chinese government issues one cord blood banking license per province, and the licensed company must function as both a public (donation-based) and private (for-profit) bank. The for-profit division funds the company’s donation-based public division, because no government support is received for this purpose. [Read more…]
One element that is common among leading cord blood banks is their involvement in strategic alliances. This is not surprising, as it is valuable for cord blood banks to establish collaborative relationships with doctors, hospitals, birthing centers, insurance companies, government entities, medical researchers, public and private donors, and more.
However, the terms and scope of key strategic alliances within the cord blood industry are often kept quiet. Other times, the partnerships are well-known within the region involved, but not well understood on a global basis. For this reason, five key alliances that substantially impact the cord blood industry are explored below. [Read more…]
This is a guest post written by the Association of Cryobanks of Cord Blood and Other Human Tissues and Cells, a Ukraine association that brings together cord blood banks and specialized cryobanks that test and store biological material, including stem cells from umbilical cord blood, bone marrow, reproductive cells and tissues.
It is a timely post as InterFax-Ukraine, a Ukraine News Agency, released an announcement two days ago stating:
The [Ukrainian] Cabinet of Ministers for deregulation of business activities in the field of health care has approved the license terms of economic activities involving the storage of umbilical cord blood and other human tissues and cells.
According to resolution No. 286 of March 2, posted on the government’s website, the document shortens the list of documents submitted for obtaining the license.
While there is undoubtedly regulatory complexity affecting cord blood banking within the Ukraine, this recent resolution suggests that the Ukrainian government is taking measures to improve the situation.
Today’s post from the Ukraine Association of Cryobanks is published with permission from Andrey Makhinya, Secretary of the Association. Enjoy! [Read more…]
After sponsoring Cord Blood World Europe in 2015, BioInformant is honored to announce that we are continuing our sponsorship for the 2016 event, held over May 18-19, 2016, at the London Business Design Centre, in London, UK.
As the first and only company to exclusively track stem cell markets, BioInformant has released a 204 page eport about the gord blood banking industry, covers breaking cord blood news on our blog, and has a partnership with the Save the Cord Foundation, titled “Cord Blood Banking Awareness: Educating America and the World.” The campaign is a global effort to educate currently expecting parents, as well as future parents, grandparents, siblings, and friends about the medical benefits of cord blood preservation.
BioInformant is deeply committed to advancing progress with cord blood, because cord blood contains valuable hematopoietic stem cells and cord tissue (“Wharton’s jelly”) contains valuable mesenchymal stem cells.